An increasing amount of evidence suggests that metabolic alterations play a key role in chronic kidney disease (CKD) pathogenesis. In this issue of the JCI, Long et al. report that the long noncoding RNA (lncRNA) taurine-upregulated 1 (Tug1) contributes to CKD development. The authors show that Tug1 regulates mitochondrial function in podocytes by epigenetic targeting of expression of the transcription factor PPAR coactivator 1 (PGC-1, encoded by Ppargc1a). Transgenic overexpression of Tug1 specifically in podocytes ameliorated diabetesinduced CKD in mice. Together, these results highlight an important connection between lncRNA-mediated metabolic alterations in podocytes and kidney disease development.
CITATION STYLE
Li, S. Y., & Susztak, K. (2016, November 1). The long noncoding RNA Tug1 connects metabolic changes with kidney disease in podocytes. Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI90828
Mendeley helps you to discover research relevant for your work.